<DOC>
	<DOC>NCT03010631</DOC>
	<brief_summary>A study to compare the pharmacokinetics and food-effect bioavailability of lubiprostone sprinkle in healthy volunteers.</brief_summary>
	<brief_title>Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers</brief_title>
	<detailed_description>To compare the pharmacokinetics of the sprinkle formulation of lubiprostone, as compared to lubiprostone capsules and to determine the effect of food on the bioavailability and plasma pharmacokinetics of lubiprostone sprinkle.</detailed_description>
	<mesh_term>Lubiprostone</mesh_term>
	<criteria>Subject is male or female, between 18 and 55 years of age, inclusive. Subject has a 12lead electrocardiogram (ECG) within normal limits and is in good health based upon review of medical history, physical examination results, vital signs (within normal range), and normal laboratory profile for both blood and urine. Subject has an active or recent history of alcoholism or drug addiction (within 1 year prior) Subject is a smoker or has a recent history of smoking (within 6 months) Subject routinely consumes food known to alter drug metabolism (i.e., grapefruit juice, coffee, tea, cola, chocolate, cocoa, or other caffeine or methylxanthine containing foods or beverages) and/or cannot refrain from these items Subject has donated blood within 3 months Subject has a medical/surgical condition that might interfere with the absorption, distribution, metabolism, or excretion of the study medication.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>